Biopharmaceutical Outsourcing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Service (Clinical Trials, Drug Discovery, API Development, Contract Production and Packaging, Non-Clinical Services, Others)

Report Code: TIPRE00018822 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

The biopharmaceutical industry is one of the significant contributors to global economic progress. Due to globalization, outsourcing of the biopharmaceutical processes has progressed to a great extent. Outsourcing also helped corporate in cost reduction and better focus on core business segments. The complexity of operations and technology-oriented industry companies started finding it feasible to outsource functions to experts. Outsourcing is the cost-saving alternative of biopharmaceutical business in the strategic decision.

MARKET DYNAMICS

Competitive market and advent of generics is an opportunity for small pharma companies to drive the augmentation of the biopharmaceutical outsourcing market. However, rising cost of drug discovery, regulatory policies and drug recalls are worry factors that may hinders the enlargement of the biopharmaceutical outsourcing market.

MARKET SCOPE

The "Biopharmaceutical Outsourcing Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of biopharmaceutical outsourcing market with detailed market segmentation by service. The biopharmaceutical outsourcing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in biopharmaceutical outsourcing market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The biopharmaceutical outsourcing market is segmented on the basis of service. Based on service, the market is segmented as clinical trials, drug discovery, api development, contract production and packaging, non-clinical services, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the biopharmaceutical outsourcing market based onvarious segments.It also provides market size and forecast estimates from year 2020 to2028with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The biopharmaceutical outsourcing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting biopharmaceutical outsourcing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the biopharmaceutical outsourcing market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the biopharmaceutical outsourcing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from biopharmaceutical outsourcing market are anticipated to have lucrative growth opportunities in the future with the rising demand for biopharmaceutical outsourcing in the global market. Below mentioned is the list of few companies engaged in the biopharmaceutical outsourcing market.

The report also includes the profiles of key players in biopharmaceutical outsourcing market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- SARTORIUS AG
- EMCURE PHARMACEUTICALS LTD
- BIOPHARMA SERVICES INC.
- LAMBDA THERAPEUTIC RESEARCH LTD.
- BAXTER HEALTHCARE CORPORATION
- KEYRUS BIOPHARMA
- QUINTILES INC.
- APTUIT LLC
- KBI BIOPHARM
- ICON PLC
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Biopharmaceutical Outsourcing Market - By Service
1.3.2 Biopharmaceutical Outsourcing Market - By Region
1.3.2.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BIOPHARMACEUTICAL OUTSOURCING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BIOPHARMACEUTICAL OUTSOURCING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BIOPHARMACEUTICAL OUTSOURCING MARKET - GLOBAL MARKET ANALYSIS
6.1. BIOPHARMACEUTICAL OUTSOURCING - GLOBAL MARKET OVERVIEW
6.2. BIOPHARMACEUTICAL OUTSOURCING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. BIOPHARMACEUTICAL OUTSOURCING MARKET - REVENUE AND FORECASTS TO 2028 - SERVICE
7.1. OVERVIEW
7.2. SERVICE MARKET FORECASTS AND ANALYSIS
7.3. CLINICAL TRIALS
7.3.1. Overview
7.3.2. Clinical Trials Market Forecast and Analysis
7.4. DRUG DISCOVERY
7.4.1. Overview
7.4.2. Drug Discovery Market Forecast and Analysis
7.5. API DEVELOPMENT
7.5.1. Overview
7.5.2. API Development Market Forecast and Analysis
7.6. CONTRACT PRODUCTION AND PACKAGING
7.6.1. Overview
7.6.2. Contract Production and Packaging Market Forecast and Analysis
7.7. NON-CLINICAL SERVICES
7.7.1. Overview
7.7.2. Non-Clinical Services Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. BIOPHARMACEUTICAL OUTSOURCING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Biopharmaceutical Outsourcing Market Overview
8.1.2 North America Biopharmaceutical Outsourcing Market Forecasts and Analysis
8.1.3 North America Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Service
8.1.4 North America Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Countries
8.1.4.1 United States Biopharmaceutical Outsourcing Market
8.1.4.1.1 United States Biopharmaceutical Outsourcing Market by Service
8.1.4.2 Canada Biopharmaceutical Outsourcing Market
8.1.4.2.1 Canada Biopharmaceutical Outsourcing Market by Service
8.1.4.3 Mexico Biopharmaceutical Outsourcing Market
8.1.4.3.1 Mexico Biopharmaceutical Outsourcing Market by Service
8.2. EUROPE
8.2.1 Europe Biopharmaceutical Outsourcing Market Overview
8.2.2 Europe Biopharmaceutical Outsourcing Market Forecasts and Analysis
8.2.3 Europe Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Service
8.2.4 Europe Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Biopharmaceutical Outsourcing Market
8.2.4.1.1 Germany Biopharmaceutical Outsourcing Market by Service
8.2.4.2 France Biopharmaceutical Outsourcing Market
8.2.4.2.1 France Biopharmaceutical Outsourcing Market by Service
8.2.4.3 Italy Biopharmaceutical Outsourcing Market
8.2.4.3.1 Italy Biopharmaceutical Outsourcing Market by Service
8.2.4.4 Spain Biopharmaceutical Outsourcing Market
8.2.4.4.1 Spain Biopharmaceutical Outsourcing Market by Service
8.2.4.5 United Kingdom Biopharmaceutical Outsourcing Market
8.2.4.5.1 United Kingdom Biopharmaceutical Outsourcing Market by Service
8.2.4.6 Rest of Europe Biopharmaceutical Outsourcing Market
8.2.4.6.1 Rest of Europe Biopharmaceutical Outsourcing Market by Service
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Biopharmaceutical Outsourcing Market Overview
8.3.2 Asia-Pacific Biopharmaceutical Outsourcing Market Forecasts and Analysis
8.3.3 Asia-Pacific Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Service
8.3.4 Asia-Pacific Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Biopharmaceutical Outsourcing Market
8.3.4.1.1 Australia Biopharmaceutical Outsourcing Market by Service
8.3.4.2 China Biopharmaceutical Outsourcing Market
8.3.4.2.1 China Biopharmaceutical Outsourcing Market by Service
8.3.4.3 India Biopharmaceutical Outsourcing Market
8.3.4.3.1 India Biopharmaceutical Outsourcing Market by Service
8.3.4.4 Japan Biopharmaceutical Outsourcing Market
8.3.4.4.1 Japan Biopharmaceutical Outsourcing Market by Service
8.3.4.5 South Korea Biopharmaceutical Outsourcing Market
8.3.4.5.1 South Korea Biopharmaceutical Outsourcing Market by Service
8.3.4.6 Rest of Asia-Pacific Biopharmaceutical Outsourcing Market
8.3.4.6.1 Rest of Asia-Pacific Biopharmaceutical Outsourcing Market by Service
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Biopharmaceutical Outsourcing Market Overview
8.4.2 Middle East and Africa Biopharmaceutical Outsourcing Market Forecasts and Analysis
8.4.3 Middle East and Africa Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Service
8.4.4 Middle East and Africa Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Biopharmaceutical Outsourcing Market
8.4.4.1.1 South Africa Biopharmaceutical Outsourcing Market by Service
8.4.4.2 Saudi Arabia Biopharmaceutical Outsourcing Market
8.4.4.2.1 Saudi Arabia Biopharmaceutical Outsourcing Market by Service
8.4.4.3 U.A.E Biopharmaceutical Outsourcing Market
8.4.4.3.1 U.A.E Biopharmaceutical Outsourcing Market by Service
8.4.4.4 Rest of Middle East and Africa Biopharmaceutical Outsourcing Market
8.4.4.4.1 Rest of Middle East and Africa Biopharmaceutical Outsourcing Market by Service
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Biopharmaceutical Outsourcing Market Overview
8.5.2 South and Central America Biopharmaceutical Outsourcing Market Forecasts and Analysis
8.5.3 South and Central America Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Service
8.5.4 South and Central America Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Biopharmaceutical Outsourcing Market
8.5.4.1.1 Brazil Biopharmaceutical Outsourcing Market by Service
8.5.4.2 Argentina Biopharmaceutical Outsourcing Market
8.5.4.2.1 Argentina Biopharmaceutical Outsourcing Market by Service
8.5.4.3 Rest of South and Central America Biopharmaceutical Outsourcing Market
8.5.4.3.1 Rest of South and Central America Biopharmaceutical Outsourcing Market by Service
9. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BIOPHARMACEUTICAL OUTSOURCING MARKET
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Middle East and Africa
9.5 South and Central America
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. BIOPHARMACEUTICAL OUTSOURCING MARKET, KEY COMPANY PROFILES
11.1. SARTORIUS AG
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. EMCURE PHARMACEUTICALS LTD
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BIOPHARMA SERVICES INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. LAMBDA THERAPEUTIC RESEARCH LTD.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BAXTER HEALTHCARE CORPORATION
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. KEYRUS BIOPHARMA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. QUINTILES INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. APTUIT LLC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. KBI BIOPHARM
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ICON PLC
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. SARTORIUS AG
2. EMCURE PHARMACEUTICALS LTD
3. BIOPHARMA SERVICES INC.
4. LAMBDA THERAPEUTIC RESEARCH LTD.
5. BAXTER HEALTHCARE CORPORATION
6. KEYRUS BIOPHARMA
7. QUINTILES INC.
8. APTUIT LLC
9. KBI BIOPHARM
10. ICON PLC
TIPRE00018822
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking